$MSOS The stay was triggered because anti-rescheduling groups want to introduce a recent Government Accountability Office (GAO) report into the record. While a delay is frustrating, addressing this evidence right now is highly positive for the market: Building an Unassailable Record: The biggest threat to cannabis stocks isn’t the DEA process itself—it is the inevitable wave of federal lawsuits from prohibitionist groups after a final Schedule III decision is made. Bulletproofing the Decision: If the judge allows the GAO report in now and the DEA successfully addresses it, that legal vulnerability is completely neutralized. It prevents opponents from suing later and claiming the DEA "ignored" vital government data. Protecting Investor Capital: For cannabis investors, a brief two-week procedural delay today is vastly superior to a federal appeals court freezing Schedule III implementation a year from now due to a rushed administrative record. The Financial Protections Remain Actively in Place It is critical for investors to separate the hearing process from the current legal status of the industry: Medical Cannabis is Already Protected: This hearing pause does absolutely nothing to roll back the historic Schedule III status already granted to state-licensed medical marijuana earlier this year. Tax Relief (Section 280E) is Secure: The core financial catalyst for cannabis stocks—the elimination of the crippling IRS 280E tax penalty for medical operators—remains actively protected by federal appeals court rulings. This stay does not pause those financial benefits. The Bottom Line This isn't a ruling on the merits of cannabis; it is routine administrative housekeeping. By ensuring every piece of data is properly litigated now, the court is clearing a cleaner, legally safer path for the final rollout. For cannabis stocks, this delay isn't a stop sign—it is just the legal system making sure the foundation is solid before building the future of the industry. FYI $MSOS we got the bot response to "tom's" article fed into their API - and stocks dumped after close. We will see how it goes tomorrow

$KNDI raises $160m from shelf offerings, then buys $120m worth of batteries from $CBAT to pump their stock, who recently also just filed and received EFFECT on a $200m shelf. $CBAT will also likely raise soon, coming full circle.

"If I issue false information, I can be jailed" -Parker Petit, CEO of public company Yesterday, Parker was convicted of securities fraud. "The securities fraud count carries a maximum sentence of 20 years in prison" CEOs. Take note. ajc.com/ajcjobs/parker-pete-…

$CVM Adam: Please stop your lies and misrepresentations. The 1st Amendment will not always protect you. On May 4 we said that the study had ended and that data lock and subsequent analysis would occur, all done by the CROs since CVM is blinded.

Episode 1 of the “I hung up on Warren Buffett” Podcast by Wolfpack Research: @Dan_David44 and Carson Block of @muddywatersre discuss @HindenburgRes report on $NKLA wolfpackresearch.podbean.com…

Thread on the aftermath of retail frenzy in Q1-Q2 2020 penny stocks. Unbelievable amount of paper sold to public hands for the benefit of company insiders and certain funds. Featuring $GNUS, $IBIO, $IDEX, shippers, $BOXL, $UAVS, $MARK, $TNXP, and a few others.🧻🖨️🧻🖨️🧻